The association between experience of COVID-19-related discrimination and psychological distress among healthcare workers for six national medical research centers in Japan.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 09 08 2022
accepted: 08 03 2023
medline: 14 8 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Discrimination is an important determinant of negative mental health outcomes. This study determined the association between the experience of COVID-19-related discrimination and psychological distress among healthcare workers (HCWs) in Japan. This cross-sectional study conducted a health survey among 5703 HCWs of six national medical and research centers in Japan from October 2020 to March 2021. COVID-19-related discrimination was defined either when participants or their family members were badmouthed or when they felt discriminated against in some way. We used the Kessler Psychological Distress Scale (K6) to assess the presence of severe psychological distress (≥ 13 points). We used logistic regression models to examine the association between discrimination and psychological distress. We also identified factors associated with discrimination. Of the participants, 484 (8.4%) reported COVID-19-related discrimination and 486 (8.5%) had severe psychological distress. HCWs who were female vs. male (adjusted odds ratio [AOR] = 1.41, 95% confidence interval [CI] = 1.28-1.55), had high vs. low viral exposure (AOR = 2.31, 95% CI = 1.81-2.93), and worked for 11 or more hours/day vs. 8 or less hours/day (AOR = 1.42, 95% CI = 1.35-1.49) were more likely to have experienced COVID-19-related discrimination. The AOR (95% CI) of severe psychological distress was 1.83 (1.29-2.59) among those who experienced discrimination. In the stratified analysis by sociodemographic and job-related factors, all the interactions did not reach statistical significance (p for interaction > 0.20). Experience of COVID-19-related discrimination was associated with severe psychological distress among HCWs. During the pandemic, effective measures should be taken to prevent the development of negative mental health outcomes in HCWs who experience discrimination.

Sections du résumé

BACKGROUND BACKGROUND
Discrimination is an important determinant of negative mental health outcomes. This study determined the association between the experience of COVID-19-related discrimination and psychological distress among healthcare workers (HCWs) in Japan.
METHODS METHODS
This cross-sectional study conducted a health survey among 5703 HCWs of six national medical and research centers in Japan from October 2020 to March 2021. COVID-19-related discrimination was defined either when participants or their family members were badmouthed or when they felt discriminated against in some way. We used the Kessler Psychological Distress Scale (K6) to assess the presence of severe psychological distress (≥ 13 points). We used logistic regression models to examine the association between discrimination and psychological distress. We also identified factors associated with discrimination.
RESULTS RESULTS
Of the participants, 484 (8.4%) reported COVID-19-related discrimination and 486 (8.5%) had severe psychological distress. HCWs who were female vs. male (adjusted odds ratio [AOR] = 1.41, 95% confidence interval [CI] = 1.28-1.55), had high vs. low viral exposure (AOR = 2.31, 95% CI = 1.81-2.93), and worked for 11 or more hours/day vs. 8 or less hours/day (AOR = 1.42, 95% CI = 1.35-1.49) were more likely to have experienced COVID-19-related discrimination. The AOR (95% CI) of severe psychological distress was 1.83 (1.29-2.59) among those who experienced discrimination. In the stratified analysis by sociodemographic and job-related factors, all the interactions did not reach statistical significance (p for interaction > 0.20).
CONCLUSION CONCLUSIONS
Experience of COVID-19-related discrimination was associated with severe psychological distress among HCWs. During the pandemic, effective measures should be taken to prevent the development of negative mental health outcomes in HCWs who experience discrimination.

Identifiants

pubmed: 36928546
doi: 10.1007/s00127-023-02460-w
pii: 10.1007/s00127-023-02460-w
pmc: PMC10020069
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1421-1429

Subventions

Organisme : Japan Health Research Promotion Bureau Research Fund
ID : 2020-B-09
Organisme : NCGM COVID-19 Gift Fund
ID : 19K059

Informations de copyright

© 2023. The Author(s).

Références

Lancet. 2020 Jun 6;395(10239):1743-1745
pubmed: 32445692
Psychol Bull. 2009 Jul;135(4):531-54
pubmed: 19586161
Eur J Psychotraumatol. 2021 Mar 10;12(1):1882781
pubmed: 33968317
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
Int J Ment Health Nurs. 2021 Dec;30(6):1674-1683
pubmed: 34374480
Ann Acad Med Singap. 2021 Mar;50(3):203-211
pubmed: 33855316
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jun 18;:
pubmed: 34153496
Front Public Health. 2020 Sep 18;8:570459
pubmed: 33072706
Int J Infect Dis. 2021 Mar;104:335-346
pubmed: 33444754
Prev Med. 2022 Aug;161:107123
pubmed: 35787841
Lancet. 2020 Sep 5;396(10252):658
pubmed: 32891198
Iran J Psychiatry. 2020 Oct;15(4):340-350
pubmed: 33240384
EMBO Mol Med. 2020 May 8;12(5):e12481
pubmed: 32275804
J Occup Health. 2021 Jan;63(1):e12228
pubmed: 33957007
Psychiatry Clin Neurosci. 2020 Oct;74(10):566-568
pubmed: 32779787
Int J Environ Res Public Health. 2021 Jun 08;18(12):
pubmed: 34201024
Front Psychiatry. 2020 Dec 11;11:579563
pubmed: 33362600
J Infect Public Health. 2021 Mar;14(3):285-289
pubmed: 33610936
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Br J Health Psychol. 2021 May;26(2):570-587
pubmed: 33278066

Auteurs

Rachana Manandhar Shrestha (RM)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan. mrachana@hosp.ncgm.go.jp.

Yosuke Inoue (Y)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Shohei Yamamoto (S)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Ami Fukunaga (A)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Makiko Sampei (M)

Department of Health Science, Health Promotion, Nippon Sport Science University, Tokyo, Japan.

Ryo Okubo (R)

Clinical Research and Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Naho Morisaki (N)

Department of Social Science, National Research Institute for Child Health and Development, Tokyo, Japan.

Norio Ohmagari (N)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Takanori Funaki (T)

Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.

Kazue Ishizuka (K)

Department of Social Science, National Research Institute for Child Health and Development, Tokyo, Japan.

Koushi Yamaguchi (K)

Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

Yohei Sasaki (Y)

Clinical Research and Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Kazuyoshi Takeda (K)

Clinical Research and Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Takeshi Miyama (T)

National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Masayo Kojima (M)

Department of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.

Takeshi Nakagawa (T)

Department of Social Science, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Soshiro Ogata (S)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Jun Umezawa (J)

Division of Cohort Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.

Shiori Tanaka (S)

Division of Prevention, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.

Manami Inoue (M)

Division of Prevention, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.

Maki Konishi (M)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Kengo Miyo (K)

Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.

Tetsuya Mizoue (T)

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH